I. Ijei

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings

L. Hsu, B. Inusa, K. Anie, 2018, F1000Research.

Prevalence of anemia and iron status among nomadic Fulani children in a grazing reserve in Northwestern Nigeria

H. Bello-Manga, A. Mamman, S. Awwalu, 2018 .

Age-related complications among individuals with sickle cell anemia attending a tertiary health facility in Northwestern Nigeria

H. Bello-Manga, S. Awwalu, Livingstone Gayus Dogara, 2019 .

Utilising the ‘Getting to Outcomes®’ Framework in Community Engagement for Development and Implementation of Sickle Cell Disease Newborn Screening in Kaduna State, Nigeria

Andrea Lamont, L. Hsu, B. Inusa, 2018, International journal of neonatal screening.

Autosplenectomy of sickle cell disease in zaria, Nigeria: an ultrasonographic assessment.

I. Ijei, J. Aiyekomogbon, A. Hassan, 2012, Oman medical journal.

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings

L. Hsu, B. Inusa, K. Anie, 2018, F1000Research.